Editorial Videos

In an interview with ACT editor, Andy Studna, Lieberman, Executive Director, Conferences (CHI) & Co-Founder, VP, Community and Business Development (ClinEco) discusses what ClinEco is and how the need to create it came about.

Sameer Lal, Sr. Vice President, Enterprise Medical Solutions at Indegene discusses their new study 'Reshaping Pharmacovigilance in the Age of AI'

In an interview with ACT editor, Andy Studna, Hesterlee, Chief Research Officer at the Muscular Dystrophy Association discusses a new therapy for Duchenne Muscular Dystrophy, Vamorolone, and what sets it apart from other therapies in the market.

New pre-competitive, disease-agnostic Consortium hopes to optimize advocacy group-industry collaboration to ultimately accelerate the pace of medicines development.

Slope.io CEO Rust Felix Discusses Phase I/II Oncology Sample Management Using Logistical Workflows

Inato Chief Strategy Officer Liz Beatty Discusses Sites that Want to Participate

Anca Copaescu, Founder and CEO of Strategikon Pharma Discusses Clinical Solutions for the Business Operations Side of Clinical Trials

Rob Bohacs, Chief Solutions Officer and Founder, ClinOne Discusses HCP and Patient Clinical Trials Recruitment

Lucille Coassin, Sr. Dir Pharma Partnerships, Current Health Discusses Connected Device Patient Monitoring